Context: Urothelial carcinoma of the bladder (UCB) displays important sexual dimorphism within the incidence, etiology, and response to intravesical immunotherapy. Environmental elements reminiscent of tobacco use
Mobile immunotherapy with chimeric antigen receptor (CAR)-T cells (CARTs) represents a breakthrough within the therapy of hematologic malignancies. CARTs are genetically engineered hybrid receptors that